Cannabis PR moved from defending the category to selling inside it. Eight shifts now define the discipline — normalization, celebrity equity, education, regulatory navigation, crisis prep, platform constraints, social equity, wellness positioning.
Cannabis operators face crisis exposure across categories few consumer brands match in combination: product safety, regulatory enforcement, license risk, financial restatement, executive matters, and reputation in a category where cultural acceptance is still evolving. Eight crisis categories, mock recall simulations, regulator-response tabletops, four-level escalation trees, dispensary communications, investor sequencing, and recovery in years not quarters.
Cannabis PR playbook — what Curaleaf, Trulieve, Cresco, Verano, and Green Thumb actually did to build credibility in a federally illegal, state-regulated category, plus where cannabis PR breaks in the AI-answer era.
Originally published July 2022 as an entry-level primer on cannabis PR fundamentals. The three foundations — budget, goals, story — remain core to any cannabis communications program. The 2026 layer on top: AI Citation Share inside ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews, which is now where cannabis discovery actually starts.
CBD is the federally legal cannabinoid that built a multi-billion-dollar parallel market — and the FDA enforcement reality that defines how the brands inside it are allowed to communicate. The CBD satellite to the cannabis communications pillar.
CBDistillery grew from $40M to projected $200M between 2018 and 2019. The CBD category never hit its $20B projection. What happened, where Balanced Health Botanicals sits in 2026, and what the case teaches about CBD marketing in the answer-engine era.
Cannabis is the only major U.S. consumer category where paid media is structurally locked out at the federal level. That removes one leg of the marketing tripod. Earned and owned are now mediated by AI engines. Citation Share is the channel. The 2026 pillar.
